Trials / Conditions / Stage IV Hepatocellular Carcinoma AJCC v7
Stage IV Hepatocellular Carcinoma AJCC v7
6 registered clinical trials studyying Stage IV Hepatocellular Carcinoma AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver NCT03217253 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder C NCT03257761 | University of Southern California | Phase 1 |
| Completed | Pembrolizumab (MK-3475) in Hepatocellular Carcinoma NCT02940496 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors NCT02143401 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be R NCT01900002 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Met NCT01015833 | National Cancer Institute (NCI) | Phase 3 |